Exploring the use of a new drug in patients with sickle cell disease. The HIBISCUS study started at the King’s College Hospital Denmark Hill campus in June 2022 with patients attending the King’s Clinical Trials Facility for their treatment. This includes a monthly medical review, examination, blood tests and to collect a further supply of the medication. The medication is pre-prescribed and collected by the trial nurses to avoid waiting for a prolonged period.
Read more here: https://ww w.maudsleybrc.nihr.ac.uk/posts/2024/october/hibiscus-study-exploring-the-use-of-a-new-drug-in-patients-with-sickle-cell-disease/
